AB0008 Type I Interferon Gene Response is Associated with Early Rheumatoid Arthritis (RA)

BackgroundRheumatoid arthritis (RA) is often accompanied by severe inflammation joint destruction and circulating autoantibodies. Recently it as been described that inflammatory responses associated with type I interferon are associated with the disease, however, there is no information regarding th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of the rheumatic diseases 2015-06, Vol.74 (Suppl 2), p.893
Hauptverfasser: Enciso-Moreno, J.A., Castañeda-Delgado, J.E., Macias-Segura, N., Santiago-Algarra, D., Castillo-Ortiz, J.D., Alemán-Navarro, A.L., Martínez-Tejada, P., García-De Lira, Y., Olgín-Calderόn, D., Enciso-Moreno, L., Bastián-Hernández, Y., Ramos-Remus, C.R.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:BackgroundRheumatoid arthritis (RA) is often accompanied by severe inflammation joint destruction and circulating autoantibodies. Recently it as been described that inflammatory responses associated with type I interferon are associated with the disease, however, there is no information regarding the role of the response of these associated gene signatures with other stages of the disease such as early RA or individuals at risk such as those with anticitrullinated antibodies and direct and family history of RA.ObjectivesTo evaluate the relative gene expression of the genes IFI44L, IFI6, IFIT1, IFIT2, IFI35, ISG15, MXB, MXA, Ly6E, RSAD2, HERC5, EPSTRI1 in blood samples isolated from patients with RA and their family members with preclinical stages of the disease.MethodsBlood samples from Mexican patients with early RA (eRA; n=10) and patients with chronic RA with more than 2 years with the disease (cRA; n=20) were collected. All cRA patients had received treatment with DMARD's. First-degree relatives of patients with RA were stratified in positive (ACCP+; n=20) or negative (ACCP-; n=20) to ACCP. Subjects without family history of autoimmune diseases were included in a healthy control group (HC; n=20). Serum levels of ACCP were evaluated using second generation ELISA. RNA was isolated and integrity was verified in a Bioanalyzer (Life Technologies), only samples with RIN scores>6 were used for cDNA synthesis by a superscript II reverse transcription system (Invitrogen), according to manufacturers instructions.qPCR analysis of the samples was carried out in a Lightcycler 480 (Roche diagnostics) and normalized using HPRT. Statistical analysis for group comparison was done using the Kruskal-Wallis test for non-parametric data, with p
ISSN:0003-4967
1468-2060
DOI:10.1136/annrheumdis-2015-eular.5358